sillajen us trial clinical
Scope
Date
~
-
Electric vehicles
Hyundai Motor to boost EV leasing in US for tax credits from 2023
South Korean electric vehicles for lease are forecast to receive US tax credits under the Inflation Reduction Act (IRA) as new guidelines of the law...
Dec 30, 2022 (Gmt+09:00)
-
Tech, Media & Telecom
SK Telecom applies mobile edge computing tech in US
SK Telecom Co. said on Thursday it had transmitted terrestrial broadcasting in the US capital of Washington D.C. using mobile edge computing (MEC) a...
Dec 30, 2022 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma, Neurolive to jointly develop new antidepressant drug
South Korea's drug company Daewoong Pharmaceutical said on Wednesday that it has signed an agreement with biopharmaceutical venture Neurorive to joi...
Dec 28, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean biotechs target US labs to speed up regulatory approval for tests
South Korean molecular diagnostics companies are increasingly buying high-quality laboratories in the US that meet federal regulatory standards in a...
Dec 28, 2022 (Gmt+09:00)
-
Chemical Industry
Samyang develops polycarbonates made of 90% recycled plastic
Samyang Corp., a food and chemical affiliate of Samyang Group, on Wednesday said it had developed South Korea's first eco-friendly polycarbonates co...
Dec 28, 2022 (Gmt+09:00)
-
Corporate restructuring
M2N to sell 52% stake in Chinese automotive parts company DKCA
M2N( DK D&I Co. ), the parent company of pharmaceutical firm Sillajen Inc., announced on Tuesday that it has signed an agreement to sell its maj...
Dec 28, 2022 (Gmt+09:00)
-
Bio & Pharma
Medipost's Cartistem shows effects on patellar cartilage defect patients
Medipost's knee osteoarthritis treatment Cartistem has been mentioned in a renowned international journal, showing that it is effective even in pati...
Dec 27, 2022 (Gmt+09:00)
-
Bio & Pharma
GI Cell wins approval for human cell management from Korean regulator
GI Cell, a South Korean developer of immune cell therapy products, received a human cell and others management license from South Korean regulatory,...
Dec 27, 2022 (Gmt+09:00)
-
Tech, Media & Telecom
Hyundai Mobis tests cutting-edge vehicle broadcast platform in North America
South Korea's Hyundai Mobis, which developed the next-generation automotive broadcast system ATSC 3.0 in the US, has teamed up with Sinclair Broadca...
Dec 27, 2022 (Gmt+09:00)
-
Bio & Pharma
CJ applies to FDA for trials of immuno-anticancer drug candidate
CJ Bioscience, an independent red bio (pharmaceutical and healthcare) subsidiary of CJ CheilJedang Corp., said on Monday it has submitted a phase 1 ...
Dec 26, 2022 (Gmt+09:00)
-
Bio & Pharma
Dong-A ST incorporates NeuroBo as subsidiary
Dong-A ST said on Friday that it would acquire American drug company NeuroBo Pharmaceuticals as a subsidiary.NeuroBo, located in Boston, is a Nasdaq...
Dec 23, 2022 (Gmt+09:00)
-
Automobiles
Hyundai Motor hits 15 mn vehicle sales milestone in US
South Korea’s auto giant Hyundai Motor Co.'s cumulative sales in the US surpassed 15 million units since entering the market in 1986, the comp...
Dec 23, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for FDA approval for Remsima SC
Celltrion Ltd. said on Friday it had applied the previous day for permission from the US Food and Drug Administration (FDA) for Remsima SC, an autoi...
Dec 23, 2022 (Gmt+09:00)
-
Content platforms
Video streaming platform Wavve acquires K-content provider KOCOWA
South Korea’s OTT platform Wavve has acquired Los Angeles-based content platform KOCOWA, short for Korean Content Wave. KOCOWA is a US online ...
Dec 22, 2022 (Gmt+09:00)
-
Electric vehicles
SK Signet to showcase new ultra-fast charger at CES 2023
SK Signet Inc., the No.1 company in the US ultra-high speed charger market, will showcase a new standard ultra-fast charger V2 at CES 2023, the worl...
Dec 22, 2022 (Gmt+09:00)
-
Asset management
US non-agency mortgage-backed securities to shine in 2023: TCW
Amid the tightening of the Federal Reserve, among the most impacted asset classes were agency mortgage-backed securities (MBS), issued by US governm...
Dec 22, 2022 (Gmt+09:00)
-
Healthcare
Naver D2SF makes investment in US sleep tech company PranaQ
Naver Corp.'s startup nurturing organization D2SF has newly invested in PranaQ, a US sleep tech startup. This is the 100th investment since the comp...
Dec 21, 2022 (Gmt+09:00)
-
Bio & Pharma
LabGenomics unites with Humanscape on Asia, US genetic testing biz
LabGenomics Co., a molecular diagnostics company, said on Tuesday that it has signed an agreement with digital healthcare company Humanscape to deve...
Dec 20, 2022 (Gmt+09:00)
-
Carbon neutrality
Samsung Heavy receives approval from US on gas recovery system
Samsung Heavy Industries, a major shipbuilder in South Korea, said on Tuesday that its boil-off gas recovery system (BReS) for LNG-powered vessels h...
Dec 20, 2022 (Gmt+09:00)
-
Artificial intelligence
Syntekabio launches new drug development platform STB Cloud in US
Syntekabio,Inc., a South Korean artificial intelligence (AI) drug development company, said on Monday it has launched its cloud-based AI drug develo...
Dec 19, 2022 (Gmt+09:00)
-
Bio & Pharma
JW Pharma applies for phase 3 trial in Taiwan for gout treatment
JW Pharmaceutical announced through its disclosure on Monday that it had applied last Friday for a phase 3 trial for Epaminurad, a gout treatment, w...
Dec 19, 2022 (Gmt+09:00)
-
Foreign exchange
Korean NPS opens up forex hedging limit to maximum of 10%
South Korea’s mighty state pension fund will hedge foreign exchange risks for up to 10% of its overseas investment for a limited period. ...
Dec 18, 2022 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma confirms safety of flu vaccine in phase 1 trial
South Korea's leading pharmaceutical company GC Biopharma Corp. said on Thursday that it has confirmed the safety and immunogenicity of the patch-ty...
Dec 15, 2022 (Gmt+09:00)
-
Bio & Pharma
Helixmith acquires US patent on new freeze-dried formulation
South Korea's biotech company Helixmith Co. said Wednesday it has developed and patented a new freeze-dried formulation for Engensis (VM202), a non-...
Dec 15, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm begins clinical trials of wearable device for detecting epilepsy
SK Group's new drug development subsidiary SK Biopharmaceuticals Co. will begin clinical trials for a wearable device that can detect and predict ep...
Dec 14, 2022 (Gmt+09:00)
-
Energy
Hanwha Q Cells to sell 7 US battery ESS projects to Spain’s Acciona Energia
Hanwha Q Cells Co., a unit of South Korea’s chemicals-to-construction conglomerate Hanwha Group, said on Wednesday it has signed a deal to sel...
Dec 14, 2022 (Gmt+09:00)
-
Energy
Hyundai Electric joins hands with GE to enter offshore wind power business
Hyundai Electric will advance into the offshore wind power market jointly with GE Renewable Energy.Hyundai Electric, an electric systems spinoff fro...
Dec 14, 2022 (Gmt+09:00)
-
Electronics
SK C&C to automate production process of SKC's US subsidiary
SK C&C announced on Wednesday that it will start a project to install a full-process automation system based on its smart factory platform I-FAC...
Dec 14, 2022 (Gmt+09:00)
-
Logistics
CJ Logistics expands global e-commerce shipping services
South Korea’s CJ Logistics Corp. is ramping up its cross-border e-commerce (CBE) businesses as its local rival Coupang Inc. is increasing domi...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
S. Korea's SillaJen launches clinical trials in US for new anti-cancer drug
South Korean biotech company Sillajen Inc. has started recruiting patients for Phase 1 clinical trials in the US for an anti-cancer drug from a Swis...
Dec 14, 2022 (Gmt+09:00)
Latest News
- 1 Hyundai Steel to displace Baoshan as GM Korea's supplier
- 2 S.Korea’s No.1 dried seaweed firm Kwangcheonkim up for sale for $295 mn
- 3 BOK chief warns against aggressive policy rate cuts, sees need for fiscal stimulus
- 4 S.Korea eases path for foreign REITs in senior housing push
- 5 Koramco targets $7 bn bets on Korea data centers